BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 35954436)

  • 1. Emerging Biomarkers and the Changing Landscape of Small Cell Lung Cancer.
    Keogh A; Finn S; Radonic T
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.
    Baine MK; Hsieh MS; Lai WV; Egger JV; Jungbluth AA; Daneshbod Y; Beras A; Spencer R; Lopardo J; Bodd F; Montecalvo J; Sauter JL; Chang JC; Buonocore DJ; Travis WD; Sen T; Poirier JT; Rudin CM; Rekhtman N
    J Thorac Oncol; 2020 Dec; 15(12):1823-1835. PubMed ID: 33011388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
    Hwang S; Hong TH; Kim HK; Choi YS; Zo JI; Shim YM; Han J; Chan Ahn Y; Pyo H; Noh JM; Lee HY; Kim HJ; Park S; Ahn MJ; Park K; Lee SH; Choi YL; Kim J
    Mod Pathol; 2023 Jul; 36(7):100184. PubMed ID: 37054974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study.
    Megyesfalvi Z; Barany N; Lantos A; Valko Z; Pipek O; Lang C; Schwendenwein A; Oberndorfer F; Paku S; Ferencz B; Dezso K; Fillinger J; Lohinai Z; Moldvay J; Galffy G; Szeitz B; Rezeli M; Rivard C; Hirsch FR; Brcic L; Popper H; Kern I; Kovacevic M; Skarda J; Mittak M; Marko-Varga G; Bogos K; Renyi-Vamos F; Hoda MA; Klikovits T; Hoetzenecker K; Schelch K; Laszlo V; Dome B
    J Pathol; 2022 Aug; 257(5):674-686. PubMed ID: 35489038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts.
    Lantuejoul S; Fernandez-Cuesta L; Damiola F; Girard N; McLeer A
    Transl Lung Cancer Res; 2020 Oct; 9(5):2233-2244. PubMed ID: 33209646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung carcinoma.
    Zhu Y; Li S; Wang H; Chi K; Ren W; Huang X; Zhuo M; Lin D
    Hum Pathol; 2023 Nov; 141():118-129. PubMed ID: 37586462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma.
    Zhu Y; Li S; Wang H; Ren W; Chi K; Wu J; Mao L; Huang X; Zhuo M; Lin D
    J Clin Pathol; 2023 Sep; ():. PubMed ID: 37775262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Therapies and Biomarkers in Small Cell Lung Cancer.
    Taniguchi H; Sen T; Rudin CM
    Front Oncol; 2020; 10():741. PubMed ID: 32509576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cell lung cancer: Subtypes and therapeutic implications.
    Wang WZ; Shulman A; Amann JM; Carbone DP; Tsichlis PN
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):543-554. PubMed ID: 35398266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP1 protein expression has variant prognostic significance in small cell lung cancer (SCLC) stratified by histological subtypes.
    Wang X; Guo Y; Liu L; Wei J; Zhang J; Xie T; Dong J; Li J; Xing P; Yang L
    Lung Cancer; 2021 Oct; 160():166-174. PubMed ID: 34364705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDM6A epigenetically regulates subtype plasticity in small cell lung cancer.
    Duplaquet L; Li Y; Booker MA; Xie Y; Olsen SN; Patel RA; Hong D; Hatton C; Denize T; Walton E; Laimon YN; Li R; Jiang Y; Bronson RT; Southard J; Li S; Signoretti S; Qiu X; Cejas P; Armstrong SA; Long HW; Tolstorukov MY; Haffner MC; Oser MG
    Nat Cell Biol; 2023 Sep; 25(9):1346-1358. PubMed ID: 37591951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity.
    Qi J; Zhang J; Liu N; Zhao L; Xu B
    Front Oncol; 2022; 12():779276. PubMed ID: 35311069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular features and evolutionary trajectory of ASCL1
    Zhang X; Wang H; Liu W; Xiao Z; Ma Z; Zhang Z; Gong W; Chen J; Liu Z
    Br J Cancer; 2023 Mar; 128(5):748-759. PubMed ID: 36517551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers.
    Qu S; Fetsch P; Thomas A; Pommier Y; Schrump DS; Miettinen MM; Chen H
    J Thorac Oncol; 2022 Jan; 17(1):141-153. PubMed ID: 34534680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC).
    Ding XL; Su YG; Yu L; Bai ZL; Bai XH; Chen XZ; Yang X; Zhao R; He JX; Wang YY
    World J Surg Oncol; 2022 Feb; 20(1):54. PubMed ID: 35220975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T-cell-inflamed phenotype in small cell lung cancer.
    Deng C; Wang Y; Fu F; Li D; Zheng Q; Jin Y; Li Y; Chen H; Zhang Y
    MedComm (2020); 2023 Oct; 4(5):e370. PubMed ID: 37789961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in regulating cell proliferation, metastasis and chemoresistance and their applications as cancer biomarkers in small cell lung cancer.
    Pandey M; Mukhopadhyay A; Sharawat SK; Kumar S
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188552. PubMed ID: 33892053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High mRNA expression of POU2F3 in small cell lung cancer cell lines predicts the effect of lurbinectedin.
    Matsui S; Haruki T; Oshima Y; Kidokoro Y; Sakabe T; Umekita Y; Nakamura H
    Thorac Cancer; 2022 Apr; 13(8):1184-1192. PubMed ID: 35278040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heterogeneity of small cell lung cancer: biological and clinicopathological implications].
    Megyesfalvi Z; Bárány N; Valkó Z; Bugyik E; Paku S; Berta J; Lantos A; Fillinger J; Moldvay J; Bogos K; Rezeli M; Gálffy G; Lang C; Lohinai Z; Hécz R; Lovas T; Rényi-Vámos F; László V; Döme B
    Magy Onkol; 2020 Sep; 64(3):243-255. PubMed ID: 34608895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Landscape and Treatment Options of Shapeshifting Small Cell Lung Cancer.
    Gu Y; Benavente CA
    J Clin Med; 2024 May; 13(11):. PubMed ID: 38892831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.